INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Sophomore Lyla Iannacconeis is undergoing testing for a heart condition discovered last year while she was dancing at Butler…
Rain chances increase tonight.
Environmentalists are concerned with a proposal that would turn the north woods at Crown Hill, into a veterans cemetery, destroying what they…
Sure fall is full of sporting events and Halloween treats, but the season also calls for festive family fun.
Creepy clown reports are popping up across the country, including here in Indiana. But now, we're hearing from an actual, honest clown…